Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with ...

His Majesty’s CPS Inspectorate has today published its report following the inspection of CPS Cymru-Wales, conducted as part of Phase 3 of the Area Inspection Programme (AIP3).

Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 ...

As the threat of WW3 looms ever closer, attention has turned to the possibility of a U.S. military draft in the event of a ...

U.S. Secretary of Education Linda McMahon granted Iowa a first-of-its-kind waiver to use millions of unrestricted federal ...

BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious ...

Daiichi Sankyo is eying new horizons for its leukemia med Vanflyta, with Genesis Pharma signing on to commercialize the drug ...

Detailed price information for Apogee Therapeutics Inc (APGE-Q) from The Globe and Mail including charting and trades.

Amorim’s exit has triggered a managerial scramble at United, with Darren Fletcher appointed interim boss and former managers ...

For patients with advanced oropharyngeal cancer, proton therapy may beat photon radiotherapy in terms of overall survival and ...

Special thanks to L.C. Norton of SB Nation’s Indiana coverage for joining me on this week’s podcast to discuss the Hoosiers’ ...

Apogee Therapeutics reports early trial data showing its asthma drug APG777 sharply reduced a key inflammation marker for up ...